Camaisa Allan, a director at Calidi Biotherapeutics, Inc. ($CLDI), made one open market sale of company shares in the last 365 days, totaling about $1,237. The most recent transaction occurred on December 12, 2025. This places Allan's sales volume at 11,536th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions per insider. Allan recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 12, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Camaisa Allan | Director | S | Common Stock | 850 | $1.46 | 76,952.0000 | 7,167,721 | 1.09% | 0.01% |
| Dec. 17, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Camaisa Allan | CEO and Chairman of the Board | S | Common Stock | 10000 | $1.62 | 66,712.0000 | 0 | 13.04% | 0.00% |
| Sept. 26, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Camaisa Allan | CEO and Chairman of the Board | A | Common Stock | 70155 | $1.15 | 76,712.0000 | 0 | 1069.93% | 0.00% |
| June 17, 2024 | Calidi Biotherapeutics, Inc. | $CLDI | Camaisa Allan | CEO and Chairman of the Board | A | Stock Options (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 21, 2023 | Calidi Biotherapeutics, Inc. | $CLDI | Camaisa Allan | CEO, President and Chairman | A | Non-Qualified Stock Options (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |